NXERA PHARMA CO., LTD.

Analyst Reco. Nxera Pharma Co., Ltd. OTC Markets

Equities

SOLTF

JP3431300007

Market Closed - OTC Markets Other stock markets 17:20:04 20/06/2024 BST			5-day change	1st Jan Change
9.43 ^USD	-5.70%		-.--%	-5.70%

06-27	Nxera Pharma Co Achieves Key R&D Milestone in Collaboration with AbbVie; Secures $10 Million Payment	MT
06-27	Nxera Pharma Co., Ltd. Receives USD 10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May	04-18	MT
Jefferies Adjusts Sosei Group’s Price Target to 2,100 Yen From 1,800 Yen, Keeps at Buy	03-12	MT
Jefferies Adjusts Sosei Group's Price Target to 1,800 Yen From 1,700 Yen, Keeps at Buy	01-25	MT
Jefferies Upgrades Sosei to Buy From Hold, Adjusts Price Target to 1,700 Yen From 1,600 Yen	11-30	MT
Jefferies Downgrades Sosei Group Corporation to Underperform From Buy, Adjusts Price Target to 1,800 Yen From 4,200 Yen	27/06/23	MT
Jefferies Adjusts Sosei’s Price Target to 4,200 Yen From 4,000 Yen, Keeps at Buy	06/03/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer